Open access
Open access
Powered by Google Translator Translator

Pediatrics (all articles)

M-A: Fetal and maternal outcomes after maternal biologic use during conception and pregnancy.

25 Feb, 2022 | 10:43h | UTC

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: a systematic review and meta-analysis – BJOG

 


Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes.

25 Feb, 2022 | 10:39h | UTC

Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes – British Journal of Surgery

 

Commentary on Twitter

 


Anti-inflammatory treatment of Kawasaki Disease: comparison of current guidelines and perspectives.

25 Feb, 2022 | 10:29h | UTC

Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives – Frontiers in Medicine

 


Mortality from congenital Zika Syndrome — nationwide cohort study in Brazil.

24 Feb, 2022 | 10:18h | UTC

Mortality from Congenital Zika Syndrome — Nationwide Cohort Study in Brazil – New England Journal of Medicine

 


Current State of Imaging of Pediatric Pancreatitis: AJR Expert Panel Narrative Review.

24 Feb, 2022 | 10:13h | UTC

Current State of Imaging of Pediatric Pancreatitis: AJR Expert Panel Narrative Review – American Journal of Roentgenology

 


WHO/UNICEF: More than half of parents and pregnant women exposed to aggressive formula milk marketing.

23 Feb, 2022 | 10:42h | UTC

More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization

Commentary: Aggressive’ marketing of formula milk flouts code, warns WHO as it urges curbs – The Guardian

 

Commentary on Twitter

 


PCRRT position paper on prescribing kidney replacement therapy in critically sick children with acute liver failure.

22 Feb, 2022 | 08:48h | UTC

PCRRT Expert Committee ICONIC Position Paper on Prescribing Kidney Replacement Therapy in Critically Sick Children With Acute Liver Failure – Frontiers in Pediatrics

 


Study suggests banning the promotion of soft drinks could be more effective than a sugar tax.

22 Feb, 2022 | 08:25h | UTC

Banning the promotion of soft drinks could be more effective than a sugar tax – The Conversation

Original Study: Industry levy versus banning promotion on soft drinks in Scotland: A distributional analysis – Food Policy

Related:

Association of a sweetened beverage tax with reduction in soda consumption in high school students.

Changes in food purchases after the Chilean policies on food labelling, marketing, and sales in schools: a before and after study.

UK National Food Strategy: Tax sugar and salt and prescribe veg, report says.

Perspective – Sugar-sweetened beverage taxes: Lessons to date and the future of taxation

Cohort Study: Association Between Tax on Sugar Sweetened Beverages and Soft Drink Consumption

Meta-Analysis: Impact of Sugar‐sweetened Beverage Taxes on Purchases and Dietary Intake

Cochrane Review: Environmental Interventions to Reduce the Consumption of Sugar‐sweetened Beverages and Their Effects on Health

Study: Snack Tax May be More Effective than a Sugary Drink Tax to Tackle Obesity

Sugar Tax: Why Health Experts Want it But Politicians and Industry are Resisting

The Effect of Food Price Changes on Consumer Purchases: A Randomized Experiment

Taxes on Sugar-Sweetened Beverages Associated with Reduced Consumption

Soda Tax Linked to a 50 Percent Reduction in Sugary Drink Consumption

AAP/AHA Policy Statement: Public Policies to Reduce Sugary Drink Consumption in Children and Adolescents

Fiscal policies for diet and the prevention of noncommunicable diseases – World Health Organization

The Lancet taskforce on NCDs and economics

To improve global health, tax the things that are killing us – Financial Times

Reducing cardiovascular disease burden through targeted dietary policies

Fiscal policies for the prevention of diseases

The potential impact of food taxes and subsidies on cardiovascular disease and diabetes burden and disparities

 


IPSO Pediatric Surgical Oncology Surgical Practice Guidelines.

21 Feb, 2022 | 08:44h | UTC

International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines – eCancer

 


New U.S. childhood and adolescent immunization schedule released by ACIP.

18 Feb, 2022 | 10:05h | UTC

Recommended Childhood and Adolescent Immunization Schedule: United States, 2022 – Pediatrics

See also:

Child and Adolescent Immunization Schedule: Recommendations for Ages 18 Years or Younger, United States, 2022 – Centers for Disease Control and Prevention

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2022 – CDC Morbidity and Mortality Weekly Report

 


M-A: Prevalence of anxiety and post-traumatic stress (PTS) among the parents of babies admitted to neonatal units.

18 Feb, 2022 | 08:22h | UTC

Prevalence of anxiety and post-traumatic stress (PTS) among the parents of babies admitted to neonatal units: A systematic review and meta-analysis – EClinicalMedicine

 


England to offer Covid jab to five to 11-year-olds.

17 Feb, 2022 | 10:09h | UTC

England to offer Covid jab to five to 11-year-olds – BBC

 


Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year.

17 Feb, 2022 | 09:58h | UTC

Risk factors for PICU admission and death among children and young people hospitalized with COVID-19 and PIMS-TS in England during the first pandemic year – Nature Medicine

Commentary: Studies detail risk of severe COVID-19, GI problems in kids – CIDRAP

 

Commentary on Twitter

 


Guidance for systematic integration of undernutrition in attributing cause of death in children.

17 Feb, 2022 | 08:46h | UTC

Guidance for Systematic Integration of Undernutrition in Attributing Cause of Death in Children – Clinical Infectious Diseases

 


External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy.

17 Feb, 2022 | 08:21h | UTC

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy – European Journal of Preventive Cardiology

 

Commentary on Twitter

 


Review: Viloxazine in the treatment of attention deficit hyperactivity disorder.

17 Feb, 2022 | 08:17h | UTC

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder – Frontiers in Psychiatry

 


Seminar: Measles.

16 Feb, 2022 | 10:15h | UTC

Measles – The Lancet (free registration required)

See also: Measles Infographics

 

Commentary on Twitter

 


M-A: Global prevalence of meeting screen time guidelines among children 5 years and younger.

16 Feb, 2022 | 08:40h | UTC

Global Prevalence of Meeting Screen Time Guidelines Among Children 5 Years and Younger: A Systematic Review and Meta-analysis – JAMA Pediatrics

Commentary: Kids using screens more than recommended, new study finds – ABC News

Related Guidelines:

Media and Young Minds – American Academy of Pediatrics

Guidelines on Screen Time and Digital Wellness in Infants, Children and Adolescents – “children below 2 years age should not be exposed to any type of screen, whereas exposure should be limited to a maximum of one hour of supervised screen time per day for children 24-59 months age, and less than two hours per day for children 5-10 years age”.

 

Commentary on Twitter

 


Podcast | Failure to Thrive – Growing into Focused Management.

16 Feb, 2022 | 08:34h | UTC

#39: Failure to Thrive – Growing into Focused Management – The Cribsiders

 


ACR Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19.

15 Feb, 2022 | 10:17h | UTC

American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3 – Arthritis & Rheumatism

Commentary and summary: ACR Updates Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With COVID – RheumNow

 


Study identifies risk factors for severe CoviD-19 in children.

15 Feb, 2022 | 10:01h | UTC

Risk Factors for Severe COVID-19 in Children – Pediatrics

 


Rickets guidance: part I—diagnostic workup.

15 Feb, 2022 | 09:51h | UTC

Rickets guidance: part I—diagnostic workup – Pediatric Nephrology

 


Cluster RCT: An educational safety-promoting program in neonatal intensive care units reduced the rate of adverse events.

15 Feb, 2022 | 08:27h | UTC

An educational programme in neonatal intensive care units (SEPREVEN): a stepped-wedge, cluster-randomised controlled trial – The Lancet (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in children under 5.

13 Feb, 2022 | 22:51h | UTC

Pfizer and FDA pull back from plan to expedite review of Covid-19 vaccine in young children – STAT

See also:

COVID-19 vaccine for kids under 5 delayed as Pfizer extends trial – CIDRAP

Pfizer postpones FDA request for Covid vaccine for kids under 5 – NBC News

 


Novavax says protein vaccine works for kids as young as 12.

13 Feb, 2022 | 22:54h | UTC

Novavax says protein vaccine works for kids as young as 12 – Associated Press

Press Release: Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial

Related:

Randomized trial with nearly 30.000 individuals showed Novavax vaccine was safe and had an overall efficacy of 90.4% against symptomatic infections.

RCT: Novavax vaccine conferred 89.7% protection against symptomatic SARS-CoV-2 infection and 100% protection against hospitalizations or deaths.

Opinion | The mRNA vaccines are extraordinary, but Novavax is even better.

(Press release – not published yet) Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease.

RCT: Novavax vaccine is 49.4% effective against B.1.351 SARS-CoV-2 variant.

[Press release – not published yet] Novavax reports 96% efficacy against original strain of COVID-19, 86% efficacy against B.1.1.7 variant, and 55% efficacy against B1.351 variant

New COVID-19 vaccines: here’s how the promising Novavax and Johnson & Johnson jabs work

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.